Диссертация (1174281), страница 21
Текст из файла (страница 21)
– 2005. – Vol. 3 – P. 1611–1617.13.Martinez, C. Epidemiology of first and recurrent venous thromboembolism: apopulation-based cohort study in patients without active cancer / C. Martinez, A.T.Cohen, L. Bamber [et al.]// Thromb Haemost. – 2014. – Vol. 112(2) – P. 255-263.14.Huang, W. Secular trends in occurrence of acute venous thromboembolism: theWorcester VTE study (1985-2009)/W. Huang, R.J.
Goldberg, F.A. Anderson//Am J Med.– 2014. – Vol. 127 – P. 829–839.15.Cohen, A.T. Venous thromboembolism (VTE) in Europe. The number of VTEevents and associated morbidity and mortality/A.T. Cohen, G. Agnelli, F.A. Anderson [etal.]// Thromb Haemost. - 2007. – Vol. 98(4) – P. 756–76416.Российские клинические рекомендации по диагностике, лечению ипрофилактике венозных тромбоэмболических осложнений // Флебология – 2010. N 4:2. С.
6-27.17.Heit, J.A. 3rd Predictors of survival after deep vein thrombosis and pulmonaryembolism: a population-based, cohort study/ J.A. Heit, M.D. Silverstein, D.N. Mohr [etal]//Arch Intern Med. - 1999. – Vol. 159 – P. 445–453.18.Яковлева, М.В. Рецидивирующая тромбоэмболия легочной артерии:клинико-инструментальнаядиагностика,течение,рентгенэндоваскулярная146профилактика: дисс…. канд. мед. наук: 14.00.06/Яковлева Марина Валентиновна.- М., 2005. - 133 с.19.Cohen, A.T. Venous thromboembolism risk and prophylaxis in the acute hospitalcare setting (ENDORSE study): a multinational cross-sectional study/A.T. Cohen, V.F.Tapson, J.F.
Bergmann [et al.]//Lancet. – 2008. – Vol. 371 – P. 387–394.20.Профилактикапослеоперационныхвенозныхтромбоэмболическихосложнений». – М.: Российский Консенсус, 2000. – 20 с.21.Aujesky, D. Derivation and validation of a prognostic model for pulmonaryembolism /D. Aujesky, D.S. Obrosky, R.A. Stone [et al.]//Am J Respir Crit Care Med. –2005. - Vol. 172 – P.
1041–1046.22.Jiménez, D. Simplification of the Pulmonary Embolism Severity Index forPrognostication in Patients With Acute Symptomatic Pulmonary Embolism/D. Jiménez,D. Aujesky, L. Moores [et al]//Arch Intern Med. – 2010. – Vol. 170(15) – P. 1383-1389.23.Klok, F.A. Brain-type natriuretic peptide levels in the prediction of adverseoutcome in patients with pulmonary embolism: a systematic review and metaanalysis/F.A. Klok, I.C.M. Mos, M.V. Huisman//Am J Respir Crit Care Med. – 2008.
–Vol. 178 – P. 425–430.24.Grifoni, S. Short-term clinical outcome of patients with pulmonary embolism,normal blood pressure, and echocardiographic right ventricular dysfunction/S. Grifoni, I.Olivotto, P. Cecchini//Circulation. – 2000. – Vol. 101 – P. 2817–2822.25.Kucher, N. Prognostic role of echocardiography among patients with acutepulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher/N.
Kucher,E. Rossi, M. De Rosa//Arch Intern Med. – 2005. – Vol. 165 – P. 1777–1781.26.Becattini, C. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis/C. Becattini, M.C. Vedovati, G. Agnelli//Circulation. - 2007. - Vol. 116(4). –P. 427-433.14727.Jiménez, D. Troponin-based risk stratification of patients with acute non-massivepulmonary embolism: systematic review and meta-analysis. / D. Jiménez, F. Uresandi, R.Otero [et al.]//Chest.
– 2009. – Vol. 136(4). – P. 974-982.28.Douketis, J.D. The incidence and prognostic significance of elevated cardiactroponins in patients with submassive pulmonary embolism/J.D. Douketis, O.Leeuwenkamp, P. Grobara P [et al.]//J Thromb Haemost. – 2005. – Vol. 3 – P. 508–51329.Jimeґnez, D. Troponin I and risk stratification of patients with acute nonmassivepulmonary embolism/D.
Jimeґnez, G. Dнaz, J. Molina [et al.]//Eur Respir J. - 2008.- Vol.31 – P. 847–853.30.Jimeґnez, D. Prognostic models for selecting patients with acute pulmonaryembolism for initial outpatient treatment/D. Jimeґnez , R.D. Yusen, R. Otero [etal.]//Chest. – 2007. – Vol. 132 – p. 24–3031.Bajaj, A. Prognostic value of troponins in acute non-massive pulmonary embolism:A meta-analysis. / A.
Bajaj, M. Saleeb, P. Rathor [et al.] // Heart Lung – 2015. – Vol.44(4). – P. 327-334.32.Ozsu, S. Predictive value of troponins and simplified pulmonary embolism severityindex in patients with normotensive pulmonary embolism/S. Ozsu, Y. Abul, A. Orem [etal.]//Multidiscip Respir Med. – 2013. - Vol. 8- P. 3433.Singanayagam, A. Are biomarkers additive to pulmonary embolism severity indexfor severity assessment in normotensive patients with acute pulmonary embolism?/A.Singanayagam, C. Scally, M.Z.
Al-Khairalla [et al.]//QJM. – 2011. – Vol. 104 – P. 125–131.34.Spirk, D. Cardiac troponin testing and the simplified pulmonary embolism severityindex the Swiss venous thromboembolism registry (SWIVTER)/D. Spirk, D. Aujesky,M. Husmann [et al.]//Thromb Haemost. – 2011. – Vol. 106 – P. 978–984.35.Moores, L.
Pulmonary Embolism Severity Index and troponin testing for theselection of low-risk patients with acute symptomatic pulmonary embolism/L. Moores,D. Aujesky, D. Jimenez [et al.] // J. Thromb. Haemost. – 2010. – Vol. 8 – P. 517–522.14836.Palmieri, V. Troponin I and right ventricular dysfunction for risk assessment inpatients with nonmassive pulmonary embolism in the Emergency Department incombination with clinically based risk score/V. Palmieri, G. Gallotta, D.
Rendina [etal.]//Intern Emerg Med. – 2008. – Vol. 3 – P. 131–138.37.Becattini, C. Acute pulmonary embolism: external validation of an integrated riskstratification model/C. Becattini, F. Casazza, C. Forgione [et al.]//Chest. – 2013. – Vol.144(5) – P. 1539–1545.38.Bova, C. Identification of intermediate-risk patients with acute symptomaticpulmonary embolism/C. Bova, O.
Sanchez, P. Prandoni P [et al.]//Eur Respir J. – 2014 Epub.39.Sanchez, O. Prognostic factors for pulmonary embolism: the prep study, aprospective multicenter cohort study/O. Sanchez, L. Trinquart, V. Caille [et al.]//Am JRespir Crit Care Med. – 2010. – Vol. 181(2) – P. 168–173.40.Agterof, M.J.
A prognostic model for short term adverse events in normotensivepatients with pulmonary embolism/M.J. Agterof, R.E. Schutgens, N. Moumli [et al.]//AmJ Hematol. – 2011. – Vol. 86(8 – P. 646–649.41.Jime´nez, D. Derivation and validation of multimarker prognostication fornormotensive patients with acute symptomatic pulmonary embolism/D. Jime´nez, D.Kopecna, V. Tapson [et al.]//Am J Respir Crit Care Med. – 2014. – Vol.
189(6) – P. 718–726.42.Coutance, G. Prognostic value of brain natriuretic peptide in acute pulmonaryembolism/G. Coutance, O. Le Page, T. Lo [et al.]//Crit Care. – 2008. - Vol. 12(4) – P.109.43.Klok, F.A. Brain-type natriuretic peptide levels in the prediction of adverseoutcome in patients with pulmonary embolism: a systematic review and metaanalysis/F.A.
Klok, I.C. Mos, M.V. Huisman//Am J Respir Crit Care Med. – 2008. – Vol.178(4) – P. 425–430.14944.Lankeit, M. Validation of N-terminal pro-brain natriuretic peptide cut-off valuesfor risk stratification of pulmonary embolism/M. Lankeit, D. Jiménez, M. Kostrubiec [etal.]//Eur Respir J. – 2014. – Vol. 43 – P. 1669–1677.45.Jaff, M.R. Management of massive and submassive pulmonary embolism,iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension.A scientific statement from the American Heart Association.[электронный ресурс]/M.R. Jaff, M.S. McMurtry, S.L. Archer [et al.] // 2011.
-Режим доступа:http://dx.doi.org/10.1161/CIR.0b013e318214914f46.Lega, J-C. Natriuretic peptides and troponins in pulmonary embolism: a meta-analysis/J-C. Lega, Y. Lacasse, L. Lakhal [et al.]//Thorax. – 2009. – Vol. 64 – P. 869–875.47.Kleine, A.H. Release of heart fatty acid-binding protein after acute myocardialinfarction in man/A.H. Kleine, J.F.C. Glatz, F.A.van Nieuwenhoven [et al.]//Mol CellBiochem. – 1992.- Vol. 116 – P.
155-162.48.Glatz, J.F. Release of fatty acidbinding protein from isolated rat heart subjected toischemia and reperfusion or to the calcium paradox/J.F. Glatz, M. van Bilsen, R.J.Paulussen [et al.]//Biochim Biophys Acta. – 1988. – Vol. 961(1) – P. 148—152.49.Мартынов, А.И. Клиническая эффективность ранней диагностики острогоинфаркта миокарда с помощью белка, связывающего жирные кислоты/А.И.Мартынов, М.И.
Воевода, Г.П. Арутюнов и соавт//РКЖ. – 2012. - № 3 – С. 7-11.50.Челобанов, Б. П. Аналитические характеристики экспресс-тестов дляиммунохроматографического анализа/Б.П. Челобанов, Г.Н. Афиногенова, И.О.Чешенко и cоавт.//Лаборатория – 2010. - № 2 – С. 17–18.51.Alhashemi,J.A.Diagnosticaccuracyofabedsidequalitativeimmunochromatographic test for acute myocardial infarction/ J. A. Alhashemi //Am JEmergency Med.
- 2006/ - Vol. 24 – P. 149–155.52.Dellas, C. Elevated heart-type fatty acid-binding protein levels on admissionpredict an adverse outcome in normotensive patients with acute pulmonary embolism/150Dellas C, Puls M, Lankeit M [et al.]//J Am Coll Cardiol. – 2010. – Vol. 55(19) – P. 2150–2157.53.Lankeit, M. The predictive value of heart-type fatty acid-binding proteinisindependent from symptom duration in normotensive patients with pulmonaryembolism/M. Lankeit, C.
Dellas, V. Benz [et al]//Thromb Res. – 2013. – Vol. 132(5) – P.543-547.54.Bajaj, A. Risk stratification in acute pulmonary embolism with heart-type fattyacid-binding protein: A meta-analysis/A. Bajaj//Chest. – 2014. – Vol. 146(6). - eP. 236237.55.Ruan, L.B. Prognostic value of plasma heart-type fatty acid-binding protein inpatients with acute pulmonary embolism: a meta-analysis/L.B.
Ruan, L. He, S. Zhao [etal.]//Chest – 2014. –Vol. 146(6) – P.1462-1467.56.Liu, M. Prognostic role of heart-type fatty acid binding protein in pulmonaryembolism: a meta-analysis/M. Liu, X. Yuan, X. Qiu [et al.] // Thromb. Res. - 2015.- Vol.135(1) – P. 20-25.57.Lankeit, M. A simple score for rapid risk assessment of non-high-risk pulmonaryembolism/M. Lankeit, D. Friesen, K. Schafer [et al.]//Clin Res Cardiol. – 2013. – Vol.102(1) – P. 73–80.58.Becattini, C. D-dimer for risk stratification in patients with acute pulmonaryembolism/C. Becattini, A.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
